Adial Pharmaceuticals (ADIL) Stock Analysis & Price (Updated Oct 16, 2026, 4:00 PM ET)
Updated Oct 16, 2026, 4:00 PM ET
ADIL jumps 11.1% to $3.49. Closed at $3.49, +11.15% vs the prior close of $3.14. Day range $3.07–$3.66, opened at $3.07.
ADIL daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 16, 2026 — ADIL jumps 11.1% to $3.49
- Closed at $3.49, +11.15% vs the prior close of $3.14. Day range $3.07–$3.66, opened at $3.07.
- Volume was 56.36K shares, 1.0x its 50-day average of 57.07K.
- Price is -27.6% vs its 50-day average ($4.82) and +5.2% vs its 200-day average ($3.32).
- 52-week range $1.31–$10.00; today's close sits at 25% of that range, 65.1% below the 52-week high.
Oct 15, 2026 — ADIL jumps 4.7% to $3.14
- Closed at $3.14, +4.67% vs the prior close of $3.00. Day range $3.00–$3.30, opened at $3.00.
- Volume was 13.90K shares, 0.2x its 50-day average of 59.12K — lighter than usual.
- Price is -35.2% vs its 50-day average ($4.84) and -5.6% vs its 200-day average ($3.33).
- 52-week range $1.31–$10.25; today's close sits at 20% of that range, 69.4% below the 52-week high.
Oct 14, 2026 — ADIL slides 8.8% to $3.00, a 1-month low, 5 down days in a row
- Closed at $3.00, -8.81% vs the prior close of $3.29. Day range $3.00–$3.32, opened at $3.17.
- Volume was 27.40K shares, 0.4x its 50-day average of 61.02K — lighter than usual.
- Price is -38.3% vs its 50-day average ($4.86) and -10.2% vs its 200-day average ($3.34).
- 52-week range $1.31–$10.25; today's close sits at 19% of that range, 70.7% below the 52-week high.
- That makes 5 straight losses.
Oct 13, 2026 — ADIL slides 6.0% to $3.29, a 1-month low, 4 down days in a row
- Closed at $3.29, -6.00% vs the prior close of $3.50. Day range $3.20–$3.87, opened at $3.52.
- Volume was 75.40K shares, 1.2x its 50-day average of 61.51K.
- Price is -32.6% vs its 50-day average ($4.88) and -1.9% vs its 200-day average ($3.35).
- 52-week range $1.31–$10.25; today's close sits at 22% of that range, 67.9% below the 52-week high.
- That makes 4 straight losses.
Oct 12, 2026 — ADIL slides 10.3% to $3.50, a 1-month low on 2.8x normal volume
- Closed at $3.50, -10.26% vs the prior close of $3.90. Day range $3.47–$4.04, opened at $4.04.
- Volume was 167.00K shares, 2.8x its 50-day average of 59.20K — unusually heavy trading.
- Price is -28.4% vs its 50-day average ($4.89) and +3.9% vs its 200-day average ($3.37).
- 52-week range $1.31–$10.50; today's close sits at 24% of that range, 66.7% below the 52-week high.
- That makes 3 straight losses.
Oct 9, 2026 — ADIL dips 1.8% to $3.90, a 1-month low
- Closed at $3.90, -1.76% vs the prior close of $3.97. Day range $3.90–$4.06, opened at $4.03.
- Volume was 3.00K shares, 0.0x its 50-day average of 61.13K — lighter than usual.
- Price is -20.1% vs its 50-day average ($4.88) and +15.3% vs its 200-day average ($3.38).
- 52-week range $1.31–$10.75; today's close sits at 27% of that range, 63.7% below the 52-week high.
Oct 8, 2026 — ADIL dips 0.5% to $3.97, a 1-month low
- Closed at $3.97, -0.50% vs the prior close of $3.99. Day range $3.92–$4.05, opened at $4.02.
- Volume was 4.90K shares, 0.1x its 50-day average of 62.74K — lighter than usual.
- Price is -18.5% vs its 50-day average ($4.87) and +17.0% vs its 200-day average ($3.39).
- 52-week range $1.31–$10.75; today's close sits at 28% of that range, 63.1% below the 52-week high.
Oct 7, 2026 — ADIL ends flat (+0.3%) to $3.99
- Closed at $3.99, +0.25% vs the prior close of $3.98. Day range $3.91–$4.09, opened at $3.91.
- Volume was 4.40K shares, 0.1x its 50-day average of 63.93K — lighter than usual.
- Price is -17.8% vs its 50-day average ($4.85) and +17.3% vs its 200-day average ($3.40).
- 52-week range $1.31–$10.75; today's close sits at 28% of that range, 62.9% below the 52-week high.
Oct 6, 2026 — ADIL slides 8.5% to $3.98, a 1-month low
- Closed at $3.98, -8.51% vs the prior close of $4.35. Day range $3.98–$4.50, opened at $4.38.
- Volume was 11.90K shares, 0.2x its 50-day average of 64.62K — lighter than usual.
- Price is -17.6% vs its 50-day average ($4.83) and +16.6% vs its 200-day average ($3.41).
- 52-week range $1.31–$10.75; today's close sits at 28% of that range, 63.0% below the 52-week high.
Oct 5, 2026 — ADIL jumps 5.6% to $4.35
- Closed at $4.35, +5.58% vs the prior close of $4.12. Day range $3.92–$4.43, opened at $4.05.
- Volume was 60.00K shares, 0.9x its 50-day average of 64.18K.
- Price is -9.6% vs its 50-day average ($4.81) and +26.9% vs its 200-day average ($3.43).
- 52-week range $1.31–$10.75; today's close sits at 32% of that range, 59.5% below the 52-week high.
Oct 2, 2026 — ADIL ends flat (-0.2%) to $4.12
- Closed at $4.12, -0.24% vs the prior close of $4.13. Day range $3.92–$4.66, opened at $4.13.
- Volume was 64.50K shares, 1.0x its 50-day average of 63.14K.
- Price is -13.8% vs its 50-day average ($4.78) and +19.8% vs its 200-day average ($3.44).
- 52-week range $1.31–$10.75; today's close sits at 30% of that range, 61.7% below the 52-week high.
- SEC filings that day: 8-K.
ADIL latest news & SEC filings
Every SEC filing by or about ADIL in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Oct 5, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Oct 2, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 8.01 — Reported other events the company considers important.
Sep 21, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 18, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 18, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 5.02 — Change in directors or officers (appointment, departure or pay).
- Item 5.07 — Reported shareholder vote results.
Sep 16, 2026 · Form DEFA14A — Additional proxy materials
Additional proxy materials
Sep 16, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 1.01 — Signed a material agreement.
- Item 8.01 — Reported other events the company considers important.
Aug 28, 2026 · Form S-3 — Shelf registration (S-3)
Shelf registration (S-3) — lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Aug 28, 2026 · Form S-8 — Employee share plan registration
Registration of shares for employee stock plans (S-8)
Aug 25, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.02 — Sold unregistered shares.
Aug 24, 2026 · Form ARS — Annual report to shareholders
Annual report to shareholders
Aug 24, 2026 · Form DEF 14A — Proxy statement
Proxy statement — agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 21, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 3.01 — Stock exchange listing notice or transfer of listing.
Things to know before you trade ADIL
- Last results release: Aug 17, 2026 (8-K Item 2.02). Previous ones: May 11, 2026, Mar 6, 2026, Nov 14, 2025. Based on that rhythm, the next report is likely around Nov 16, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 5.19% (largest 11.1%). That is a volatile stock.
- Liquidity: about 41.98K shares (≈$146.50K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $3.49 vs a range of $1.31–$10.00 (25% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: 1:25 on Feb 6, 2026
- Insider trades (Form 4, last 12 months, recent 25 shown): 20 open-market buys, 0 sales; latest: Capital Lp Coastlands bought 1,233 shares on Jul 16, 2026.
- Latest filings: 8-K Oct 16, 2026; 8-K Oct 2, 2026; 8-K Sep 18, 2026.
- Share count: 2.63M shares outstanding (Aug 12, 2026), -88.0% vs a year earlier — the company has been reducing its share count.
- Listing: Nasdaq · industry: Pharmaceutical Preparations.
ADIL market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 16, 2026 | 3.07 | 3.66 | 3.07 | 3.49 | 56.36K |
| Oct 15, 2026 | 3.00 | 3.30 | 3.00 | 3.14 | 13.90K |
| Oct 14, 2026 | 3.17 | 3.32 | 3.00 | 3.00 | 27.40K |
| Oct 13, 2026 | 3.52 | 3.87 | 3.20 | 3.29 | 75.40K |
| Oct 12, 2026 | 4.04 | 4.04 | 3.47 | 3.50 | 167.00K |
| Oct 9, 2026 | 4.03 | 4.06 | 3.90 | 3.90 | 3.00K |
| Oct 8, 2026 | 4.02 | 4.05 | 3.92 | 3.97 | 4.90K |
| Oct 7, 2026 | 3.91 | 4.09 | 3.91 | 3.99 | 4.40K |
| Oct 6, 2026 | 4.38 | 4.50 | 3.98 | 3.98 | 11.90K |
| Oct 5, 2026 | 4.05 | 4.43 | 3.92 | 4.35 | 60.00K |
| Oct 2, 2026 | 4.13 | 4.66 | 3.92 | 4.12 | 64.50K |
| Oct 1, 2026 | 4.12 | 4.45 | 3.86 | 4.13 | 13.40K |
| Sep 30, 2026 | 4.16 | 4.29 | 3.95 | 4.01 | 35.30K |
| Sep 29, 2026 | 4.04 | 4.30 | 3.97 | 4.15 | 29.30K |
| Sep 28, 2026 | 4.05 | 4.30 | 3.85 | 4.04 | 47.50K |
| Sep 25, 2026 | 4.40 | 4.56 | 4.12 | 4.22 | 33.20K |
| Sep 24, 2026 | 4.00 | 4.64 | 4.00 | 4.44 | 47.30K |
| Sep 23, 2026 | 4.25 | 4.25 | 3.77 | 4.04 | 60.90K |
| Sep 22, 2026 | 4.40 | 4.42 | 4.14 | 4.20 | 40.20K |
| Sep 21, 2026 | 4.82 | 4.82 | 4.23 | 4.40 | 43.70K |
About Adial Pharmaceuticals
Adial Pharmaceuticals (ADIL) is listed on the Nasdaq and classified by the SEC under “Pharmaceutical Preparations”. Its business address is in CHARLOTTESVILLE, VA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1513525.
ADIL board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| J. Kermit Anderson | Director | Apr 9, 2026 |
| Cary J Claiborne | Chief Executive Officer | Apr 9, 2026 |
| Matt Davidson | Chief Development Officer | Jun 16, 2026 |
| Robertson H. Gilliland | Director | Apr 9, 2026 |
| Tony Goodman | Chief Operating Officer | Apr 9, 2026 |
| Kevin Schuyler | Director | Apr 9, 2026 |
| Wendy B. Young | Director | Sep 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Cary J Claiborne | Chief Executive Officer | Apr 9, 2026 |
| Matt Davidson | Chief Development Officer | Jun 16, 2026 |
| Tony Goodman | Chief Operating Officer | Apr 9, 2026 |
| Vinay Shah | Chief Financial Officer | Apr 9, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 16, 2026 | Capital Lp Coastlands | Buy | 1,233 | $2.75 |
| Jul 16, 2026 | Capital Lp Coastlands | Buy | 1,233 | $2.75 |
| Jul 16, 2026 | Capital Lp Coastlands | Buy | 1,233 | $2.75 |
| Jul 16, 2026 | Capital Lp Coastlands | Buy | 1,233 | $2.75 |
| Jul 14, 2026 | Capital Lp Coastlands | Buy | 2,000 | $2.65 |
| Jul 14, 2026 | Capital Lp Coastlands | Buy | 2,000 | $2.65 |
| Jul 14, 2026 | Capital Lp Coastlands | Buy | 2,000 | $2.65 |
| Jul 14, 2026 | Capital Lp Coastlands | Buy | 2,000 | $2.65 |
| Jul 10, 2026 | Capital Lp Coastlands | Buy | 1,700 | $2.70 |
| Jul 10, 2026 | Capital Lp Coastlands | Buy | 1,700 | $2.70 |
| Jul 10, 2026 | Capital Lp Coastlands | Buy | 1,700 | $2.70 |
| Jul 10, 2026 | Capital Lp Coastlands | Buy | 1,700 | $2.70 |
| Jul 9, 2026 | Capital Lp Coastlands | Buy | 10,053 | $2.79 |
| Jul 9, 2026 | Capital Lp Coastlands | Buy | 10,053 | $2.79 |
| Jul 9, 2026 | Capital Lp Coastlands | Buy | 10,053 | $2.79 |
ADIL financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | — | $-7.98M | -11.93 | $-6.49M |
| Dec 31, 2024 | — | $-13.20M | -68.01 | $-6.92M |
| Dec 31, 2023 | — | $-5.12M | -3.60 | $-6.81M |
| Dec 31, 2022 | — | $-12.73M | -12.71 | $-11.19M |
| Dec 31, 2021 | — | $-19.42M | -1.04 | $-11.95M |
Latest balance sheet: total assets $29.09M, total liabilities $28.93M, cash $5.88M (as of Jun 30, 2026).
ADIL earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 17, 2026 | 8-K Item 2.02 (results) | $4.99 |
| May 11, 2026 | 8-K Item 2.02 (results) | $1.44 |
| Mar 6, 2026 | 8-K Item 2.02 (results) | $1.83 |
| Nov 14, 2025 | 8-K Item 2.02 (results) | $8.25 |
| Aug 14, 2025 | 8-K Item 2.02 (results) | $9.75 |
| May 15, 2025 | 8-K Item 2.02 (results) | $16.50 |
| Mar 4, 2025 | 8-K Item 2.02 (results) | $18.75 |
| Nov 14, 2023 | 8-K Item 2.02 (results) | — |
| Aug 21, 2023 | 8-K Item 2.02 (results) | — |
| May 12, 2023 | 8-K Item 2.02 (results) | — |
| Mar 31, 2023 | 8-K Item 2.02 (results) | — |
| Nov 15, 2022 | 8-K Item 2.02 (results) | — |
Related stocks · Pharmaceutical Preparations
Eli Lilly (LLY)Johnson & Johnson (JNJ)Merck (MRK)AbbVie (ABBV)Abbott Laboratories (ABT)Pfizer (PFE)Bristol Myers Squibb (BMY)Vertex Pharmaceuticals Inc / Ma (VRTX)Novo Nordisk A S (NVO)Regeneron Pharmaceuticals (REGN)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on ADIL
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 16, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.